Budapest Stock Exchange: Naturland Goes Public

A solemn bell-ringing ceremony marked the start of trading at the Budapest Stock Exchange (BSE) this Monday – the occasion was the public listing of Naturland Holding. The event was attended by Richárd Végh, CEO of the Budapest Stock Exchange, and Tibor Ásványi, founder of Naturland, among others.

With this issue, the company has listed 13,627,455 dematerialized ordinary shares with a nominal value of HUF 100 each on the BSE Xtend market. BDO Magyarország Pénzügyi Tanácsadó [‘Financial Advisor’] Plc. acted as the appointed advisor and AegisLegal as the legal advisor in the preparation of the IPO, according to the BSE website

Naturland Holding Plc.'s main activity is asset management, primarily through the strategic management of its subsidiary Naturland Magyarország Ltd., founded in 1998, and the exploitation of its registered trademarks in the healthcare segment. Naturland Magyarország Ltd. is a major player in the Hungarian pharmaceutical industry, which is engaged in a full range of pharmaceutical manufacturing activities, from research and development, product approval and production to independent wholesale activities. The company is a market leader in the pharmacy magistral pharmaceuticals segment and is also a dominant player in the market for non-pharmaceuticals.